GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | 8/14/2026 4:55:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2026 ending: 6/30/2026 | Rev: $1,493,788 | Assets $112,093,103 | EPS -$0.08 | |
| CITIUS ONCOLOGY, INC. (CTOR) | 8/14/2026 4:40:18 PM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $1,493,788 | Assets $112,093,103 | EPS -$0.08 | Export Earnings Model | |
| CITIUS ONCOLOGY, INC. (CTOR) | 5/29/2026 5:01:19 PM | View | Proxy | SEC | Y 2025 | ||||||
| CITIUS ONCOLOGY, INC. (CTOR) | 5/15/2026 4:46:25 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $1,667,298 | Assets $100,699,168 | EPS -$0.27 | Export Earnings Model | |
| CITIUS ONCOLOGY, INC. (CTOR) | 5/15/2026 4:45:13 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 3/31/2026 | Rev: $1,667,298 | Assets $100,699,168 | EPS -$0.27 | |
| CITIUS ONCOLOGY, INC. (CTOR) | 2/13/2026 8:31:21 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $3,944,111 | Assets $109,973,406 | EPS -$0.06 | Export Earnings Model | |
| CITIUS ONCOLOGY, INC. (CTOR) | 2/13/2026 8:13:25 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 12/31/2025 | Rev: $3,944,111 | Assets $109,973,406 | EPS -$0.06 | |
| CITIUS ONCOLOGY, INC. (CTOR) | 1/29/2026 4:32:56 PM | View | Proxy | SEC | Y 2025 | ||||||
| CITIUS ONCOLOGY, INC. (CTOR) | 12/23/2025 4:51:33 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $100,942,881 | EPS -$0.06 | Export Earnings Model | ||
| CITIUS ONCOLOGY, INC. (CTOR) | 12/23/2025 4:34:09 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 9/30/2025 | Assets $100,942,881 | EPS -$0.34 | ||
| CITIUS ONCOLOGY, INC. (CTOR) | 9/26/2025 4:31:21 PM | View | Proxy | SEC | Y 2024 | ||||||
| CITIUS ONCOLOGY, INC. (CTOR) | 8/12/2025 4:47:21 PM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $91,709,079 | EPS -$0.08 | Export Earnings Model | ||
| CITIUS ONCOLOGY, INC. (CTOR) | 8/12/2025 4:45:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 6/30/2025 | ||||
| CITIUS ONCOLOGY, INC. (CTOR) | 5/14/2025 4:43:54 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 3/31/2025 | Assets $91,439,365 | EPS -$0.11 | ||
| CITIUS ONCOLOGY, INC. (CTOR) | 5/14/2025 4:32:57 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $91,439,365 | EPS -$0.11 | Export Earnings Model | ||
| CITIUS ONCOLOGY, INC. (CTOR) | 2/24/2025 4:31:14 PM | View | Proxy | SEC | Y 2024 | ||||||
| CITIUS ONCOLOGY, INC. (CTOR) | 2/14/2025 4:45:48 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $90,481,481 | EPS -$0.09 | Export Earnings Model | ||
| CITIUS ONCOLOGY, INC. (CTOR) | 2/14/2025 4:42:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 12/31/2024 | Assets $90,481,481 | EPS -$0.09 | ||
| CITIUS ONCOLOGY, INC. (CTOR) | 1/27/2025 4:42:32 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 9/30/2024 | Assets $84,368,878 | EPS -$0.31 | ||
| CITIUS ONCOLOGY, INC. (CTOR) | 12/27/2024 5:15:09 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 9/30/2024 | Assets $84,368,878 | EPS -$0.31 | ||
| CITIUS ONCOLOGY, INC. (CTOR) | 12/27/2024 5:10:45 PM | View | Financials | Earnings | SEC | Y 2024 | Assets $84,368,878 | Export Earnings Model | |||
| CITIUS ONCOLOGY, INC. (CTOR) | 8/9/2024 4:38:25 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $49,193,627 | EPS $0.04 | ||
| TenX Keane Acquisition (CTOR) | 5/20/2024 5:38:18 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $48,679,257 | EPS $0.07 | ||
| TenX Keane Acquisition (CTOR) | 4/16/2024 5:17:29 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $72,623,594 | EPS $0.27 | ||
| TenX Keane Acquisition (CTOR) | 1/8/2024 4:47:27 PM | View | Proxy | SEC | Y 2023 | ||||||
| TenX Keane Acquisition (CTOR) | 11/20/2023 5:36:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $70,713,071 | EPS $0.02 | ||
| TenX Keane Acquisition (CTOR) | 8/16/2023 2:56:04 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | ||||
| TenX Keane Acquisition (CTOR) | 5/15/2023 4:34:45 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | ||||
| TenX Keane Acquisition (CTOR) | 4/17/2023 4:29:05 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | ||||
| TenX Keane Acquisition (CTOR) | 11/28/2022 5:18:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 |